$180-215k
+ Bonus + Equity
3 days a week in office
Medical equipment manufacturing
Be an early applicant
Medical equipment manufacturing
501-1000 employees
Be an early applicant
$180-215k
+ Bonus + Equity
3 days a week in office
501-1000 employees
To establish a new era of personalized care by delivering AI-driven analysis and insights to proactively manage CAD for life.
Jump to section
To establish a new era of personalized care by delivering AI-driven analysis and insights to proactively manage CAD for life.
4% employee growth in 12 months
HeartFlow is a medical equipment manufacturer that uses CT-scanned 3D modelling to assess and analyze a patient's heart and arteries. This non-invasive process can help assess the risks of Coronary Artery Disease (CAD) and strategize the appropriate treatment.
As the world’s leading cause of death, CAD is a worthy target for improved diagnosis and treatment. HeartFlow's approach enables clinicians to deliver more effective treatments faster, making CAD more manageable than ever before.
The company has a long history of awards and innovations, adopting technological advancements as they happen. It successfully launched its IPO in 2021, although a 2022 merger with Longview Acquisitions was called off due to unfavourable market conditions. Despite this, the company remains steadfast, unveiling new technology that ensures better treatment for CAD patients.

Steph
Company Specialist at Welcome to the Jungle
Mar 2025
$98m
CONVERTIBLE
Apr 2023
$215m
SERIES F
This company has top investors
John Farquhar
(President & CEO)Joined HeartFlow in 2021 as the President and Chief Operating Officer and became the CEO in 2022. Prior to this, they were the VP and General Manager at Medtronic. They also spent 5 years as a Professional Football Player in the NFL.
Software Engineering
People, HR, Recruitment
Finance, Legal & Compliance
Design
Sales & Account Management